Results 211 to 220 of about 40,945 (273)
Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
Neuropsychopharmacology, 2019 Lysergic acid diethylamide (LSD) is a classic psychedelic, 3,4-methylenedioxymethamphetamine (MDMA) is an empathogen, and d-amphetamine is a classic stimulant. All three substances are used recreationally.
Friederike Holze +2 more
exaly +2 more sources
Scientific Reports, 2020 The success of modern medicine creates a growing population of those suffering from life-threatening illnesses (LTI) who often experience anxiety, depression, and existential distress.
Allison A Feduccia, Lisa Jerome
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of Psychopharmacology, 2022
Background: Suicide is one of the leading causes of death worldwide and rates within the United States have risen over the past two decades. Hence, there is a critical need for novel tools to treat suicidal ideation and related mental health conditions ...
Grant M Jones, M. Nock
semanticscholar +1 more source
Background: Suicide is one of the leading causes of death worldwide and rates within the United States have risen over the past two decades. Hence, there is a critical need for novel tools to treat suicidal ideation and related mental health conditions ...
Grant M Jones, M. Nock
semanticscholar +1 more source
Journal of clinical pharmacology, 2021
This article discusses current literature on the use of 3,4‐methylenedioxymethamphetamine (MDMA)‐assisted psychotherapy in the treatment of posttraumatic stress disorder (PTSD).
Kimberly W Smith +3 more
semanticscholar +1 more source
This article discusses current literature on the use of 3,4‐methylenedioxymethamphetamine (MDMA)‐assisted psychotherapy in the treatment of posttraumatic stress disorder (PTSD).
Kimberly W Smith +3 more
semanticscholar +1 more source
Distinct neural mechanisms for the prosocial and rewarding properties of MDMA
Science Translational Medicine, 2019 MDMA, which has both therapeutic and abuse potential, engages a brain region–specific serotonergic pathway to produce its prosocial effect. Dissecting MDMA MDMA, commonly known as ecstasy, is a psychoactive drug primarily used for recreational purposes ...
Boris D Heifets +2 more
exaly +2 more sources
Annals of Clinical Psychiatry, 2007
3,4-Methylenedioxymethamphetamine (MDMA or Ecstasy) is a synthetic amphetamine analogue that is recreationally used to obtain a psychological effect of enhanced affiliative emotional response. Its use in Western countries appears to be increasing, particularly among young individuals.Pertinent basic and clinical literature is critically reviewed.A ...
Rif S, El-Mallakh, Henry David, Abraham
openaire +2 more sources
3,4-Methylenedioxymethamphetamine (MDMA or Ecstasy) is a synthetic amphetamine analogue that is recreationally used to obtain a psychological effect of enhanced affiliative emotional response. Its use in Western countries appears to be increasing, particularly among young individuals.Pertinent basic and clinical literature is critically reviewed.A ...
Rif S, El-Mallakh, Henry David, Abraham
openaire +2 more sources
Psychopharmacology, 2018 Standard therapeutic approaches to reduce social anxiety in autistic adults have limited effectiveness. Since 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy shows promise as a treatment for other anxiety disorders, a blinded, placebo ...
Allison A Feduccia +2 more
exaly +2 more sources
2023
Abstract MDMA (3,4-methylenedioxymethamphetamine) was originally synthesized and patented by the Merck chemical company in 1914. It was not explored for human use until the 1970–80s when there were published reports that it could be a useful catalyst to psychotherapy, in part because it often produced reduced anxiety and increased ...
Michael C. Mithoefer, David E. Presti
openaire +1 more source
Abstract MDMA (3,4-methylenedioxymethamphetamine) was originally synthesized and patented by the Merck chemical company in 1914. It was not explored for human use until the 1970–80s when there were published reports that it could be a useful catalyst to psychotherapy, in part because it often produced reduced anxiety and increased ...
Michael C. Mithoefer, David E. Presti
openaire +1 more source
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2018 Allison A Feduccia
exaly +2 more sources
Trends in MDMA-related mortality across four countries.
Addiction, 2021AIMS To determine trends in 3,4 methylenedioxymethamphetamine (MDMA)-related death rates across Australia, Finland, Portugal and Turkey and to analyse causes of death across countries; and 3. analyse the toxicology of deaths across countries.
A. Roxburgh +6 more
semanticscholar +1 more source